NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA
NCT02342600 2017-10-12SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)Sarcoma Alliance for Research through CollaborationPhase 2 Withdrawn